The results of correlation analyses between diagnostic RPS6KA1 and SERPINA3 gene expression and immune cells showed that RPS6KA1 correlated positively with macrophages and SERPINA3 correlated negatively with macrophages and mast cells in patients with NAFLD (Figure 9C), whereas RPS6KA1 and SERPINA3 respectively correlated positively and negatively with macrophages and mast cells in patients with AS (Figure 9D). This evidence concerns the gene RPS6KA1 and metabolic dysfunction-associated steatotic liver disease.